Skip to main content
. 2015 Mar 5;112(6):1027–1036. doi: 10.1038/bjc.2015.72

Figure 2.

Figure 2

Immunological parameters measured in the peripheral blood of patients with pancreatic cancer in the prognostic setting. FACS analysis of immune cells and granzyme B release were assessed as described in the Materials and Methods section and the data were correlated with patients' OS and/or DFS with Kaplan–Meier methods. For statistical data, see Supplementary Table S1.